Reports

Ideas That Generate Results

List of Figures:

Figure 4-1: Drugs and Pharmaceutical Export (Billion INR), FY 2005 to FY 2010
Figure 5-1: Pharmaceutical Market (Billion INR), FY 2009 to FY 2013
Figure 5-2: Generics Market (Billion INR), FY 2009 to FY 2013
Figure 5-3: Share of Generics in Pharmaceutical Market (FY 2010)
Figure 6-1: Global - Forecast for Generics Market by Region (%), 2013
Figure 6-2: Market Share of Indian Companies in US Generics Sector (2008-2010)
Figure 6-3: US - Patent Expiries (Billion US$), 2011-2015

List of Tables:

Table 4-1: Blockbuster Drugs Going Off-patent Globally (2011-2015)
Table 7-1: Key M&A in the Generics Market
Table 10-1: Ranbaxy - Strengths and Weaknesses
Table 10-2: Cipla Ltd. - Strengths and Weaknesses
Table 10-3: Jubilant - Strengths and Weaknesses
Table 10-4: Sun Pharmaceuticals - Strengths and Weaknesses
Table 10-5: Zydus Cadila - Strengths and Weaknesses
Table 10-6: Dr. Reddy's Laboratories - Strengths and Weaknesses
Table 10-7: Lupin Ltd. - Strengths and Weaknesses
Table 10-8: Aurobindo Pharma - Strengths and Weaknesses
Table 10-9: Glenmark Pharma - Strengths and Weaknesses
Table 10-10: Piramal Healthcare - Strengths and Weaknesses